{"_id":"x1eVUl6MXDQalwhQ81fRw1mDkJFmRU1Q7s8s0YB4YPNo6ES0K6SvcF","founded_year":1945,"lastupdate":"2024-05-05T00:00:00.000Z","update_date":"2024-05-05T00:00:00.000Z","lastModified":"Apr 23, 2025","confidence_score":53,"active":1,"confidence_score_reason":"product stage, sector, tags, business model, description, video or image, funding rounds, markets, not claimed","urlname":"alcon-pharmaceuticals","minimal_profile":0,"status":"Public","fullstatus":"Public on SIX on Apr, 2019;Public on NYSE on Apr, 2019;","acquired":null,"description_edited":null,"tag_line_edited":null,"phone":null,"registrar":null,"biverification":"Maor Perlov","recentupdates":[{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:42:49.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:09.000000","last_name":"Perlov","first_name":"Maor"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-23 11:32:40.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:24:10.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:09.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:30:22.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:44:02.000000","last_name":"Perlov","first_name":"Maor"},{"email":"jenny.sotnik@sncentral.org","source":"Automatic","datetime":"2025-04-23 11:32:41.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:15.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:09.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:30:21.000000","last_name":"Perlov","first_name":"Maor"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-05-05 11:47:54.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:09.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-05 14:15:53.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-22 06:27:04.000000","last_name":"Levin","first_name":"Eran"},{"email":"matane@sncentral.org","source":"Automatic","datetime":"2024-05-05 11:47:54.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:09.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:30:22.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:30:19.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:25:00.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:09.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:43:30.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:30:19.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:25:51.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2025-02-06 12:43:50.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:30:21.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:25:00.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:30:19.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:30:21.000000","last_name":"Perlov","first_name":"Maor"},{"email":"matane@sncentral.org","source":"Automatic","datetime":"2024-05-05 11:47:54.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:09.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:26:49.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:25:41.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:52.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-08-07 04:52:12.000000","last_name":"Levin","first_name":"Eran"},{"email":"jenny.sotnik@sncentral.org","source":"Automatic","datetime":"2025-04-23 11:32:55.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:30:19.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:31:33.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-08-07 04:52:12.000000","last_name":"Levin","first_name":"Eran"},{"email":"yanina.wainscheinker@sncentral.org","source":"Automatic","datetime":"2025-01-03 18:34:39.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:09.000000","last_name":"Perlov","first_name":"Maor"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-23 11:34:27.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:09.000000","last_name":"Perlov","first_name":"Maor"},{"email":"jenny.sotnik@sncentral.org","source":"Automatic","datetime":"2025-04-23 11:32:41.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:24:10.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:09.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-07-16 08:42:49.000000","last_name":"Perlov","first_name":"Maor"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-04-23 11:32:40.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-07-16 08:24:09.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-05 15:04:14.000000","last_name":"Levin","first_name":"Eran"}],"sectorverify":null,"biverify":{"id":"7JMVZ1cDkplo2zZFEs4WRWhuj0xt9r8fRw5ZIjvtKeO50MH4vxhFbX","fullname":"Maor Perlov"},"biverifydate":"2024-07-16T00:00:00.000Z","crunchbaseid":"alcon","lastupdator":null,"lastupdator_email":null,"creator":"Matan Eblagon","creator_email":"matane@sncentral.org","createdate":"2024-05-05T00:00:00.000Z","lastupdatedate":"2024-05-05","hide_reason":null,"hide_reason_data":null,"logokey":"$3DNKKAH8tfnswTSkxk6Mg1j3ZHKgFaKmE1DpOGckdhercxthLADbvg.jpeg","name":"Alcon Pharmaceuticals","israeliacquisitions":1,"forbesranking":728,"investmentarm":null,"investmentarmname":null,"hubname":null,"acquired_amount":null,"acquired_by":null,"acquired_country":null,"acquired_month":null,"acquired_year":null,"type":"Multinational","formernames":[],"alternativenames":null,"country":"Switzerland","inisraelsince":"6/2024","inisraelsincemonth":"6","isisraeli":0,"marketcapital":36531216000,"marketcapitaldate":"2025-11-01T14:09:34.000Z","oneliner":"Medical Devices and Equipment and Supplies","website":"https://www.alcon.com/","employees":"11-50","employees_exact":25,"employees_overall":"10,001-50,000","employees_overall_exact":26878,"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UCN_Zj_knZ6q85W8Oxl1nTUA/videos","facebook":"https://www.facebook.com/AlconEyeCare/","linkedin":"https://www.linkedin.com/company/5275","instagram":"https://www.instagram.com/alconlife/"},"social":["https://www.linkedin.com/company/5275","https://www.youtube.com/channel/UCN_Zj_knZ6q85W8Oxl1nTUA/videos","https://www.facebook.com/AlconEyeCare/","https://www.instagram.com/alconlife/"],"flattenedsociallinks":"https://www.linkedin.com/company/5275|https://www.youtube.com/channel/UCN_Zj_knZ6q85W8Oxl1nTUA/videos|https://www.facebook.com/AlconEyeCare/|https://www.instagram.com/alconlife/","apps":{"appstore":"","googleplay":""},"investmentstage":[],"about":"Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products.\n\nAlcon Pharmaceuticals office in Israel was established following the acquisition of Belkin Vision.","founded":"1/1945","team":[{"name":"Daria  Lemann-Blumenthal","email":"","phone":"","gender":"Female","userid":"3TY9cKvwGOQWBGBDt9jePwcHLfC66B8NcC7YwQfa4rWoDg1Y5x7LJO","bounced":false,"claimed":null,"founder":0,"urlname":"daria-lemann-blumenthal","visible":1,"memberid":"K482H9MlH5HV2f11TwLu0aRz6oPjBF5GpyuDOBfor5jpR3S2zj1ROF","position":"","last_name":" Lemann-Blumenthal","claimtoken":null,"first_name":"Daria","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/daria-lemann-blumenthal-65838111/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"D ","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"portfolio":[{"name":"BELKIN Vision","hidden":false,"raised":"$38.44M","founded":"2013","fullurl":"/company_page/belkin-laser","logokey":"$pCNp5mb4toBJ00ug4GBPqqd8F4OzHgivl1zGvU92fHhkqkoSJVcCbi.jpeg","urlname":"belkin-laser","employees":"11-50","company_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7q_akKDA","description":"One-second Laser Treatment for Glaucoma","fundingstage":"Acquired","businessmodel":"B2B","raisedNumber":38440000,"logourl":"https://storage.googleapis.com/clean-finder-353810/$pCNp5mb4toBJ00ug4GBPqqd8F4OzHgivl1zGvU92fHhkqkoSJVcCbi.jpeg","style":"","hiddenCompanyTooltip":""}],"exits":[],"mediagallery":[],"affiliatedOrganizations":null,"address":{"israeli":[{"id":"fiMPhM96r77lMTYz4b0FzVKQ2OOTGaQ2uQGwYmYKAEtdJOEoAaCQxO","city":"Yavne","type":["R&D"],"address":"Yavne, Israel","placeid":"ChIJs32SQXq6AhUR5H65MScHmUE","notactive":0,"openeddate":"2024-01-16","registrarid":"514902824","firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"Q9vswx6uHdiwj93fI6Puu3EmRCduFABif7rlHEf5EXv2mmCBhGrVoC","city":"Fort Worth","address":"Fort Worth, TX, USA","country":"United States","placeid":"ChIJrQfILRJuToYRvaxp3fiLr6Q"}]},"headquarter_address":"Switzerland","news":[{"id":"wAffUNb2X6biXLNqAdMnux9RusKIWjL9T242gZQdbYwaq11zegU9V4","date":"Aug 21, 2025","link":"https://finance.yahoo.com/news/coreweave-upgraded-instacart-downgraded-wall-133611214.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"upgrade","round":null,"company":"HP Enterprise","layoffs":null,"summary":"The article highlights recent research calls on Wall Street, focusing on upgrades and downgrades of various companies. HP Enterprise (HPE) was upgraded by Morgan Stanley to Overweight with a price target increase, indicating a positive outlook due to potential benefits from the Juniper acquisition. CoreWeave and Bio-Techne also received upgrades with increased price targets, suggesting undervaluation and growth potential. Conversely, companies like Instacart and Coty faced downgrades due to increased competition and weaker-than-expected results. The article provides insights into market perceptions and expectations for these companies.","partners":null,"customers":null,"eventType":null,"investors":[],"confidence":9,"key_topics":["upgrades","downgrades","price targets","valuation","competition"],"date_of_event":null,"product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"HBZHhkRrKuMXd8J8xTFWVZ4unMUIyGRtJnaFzxJPTgJe2eUkIm68hC","news_summary":"CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"QCIc5fHe8vpl8Y3tQBE1GvaNZ6nEJTMPJIToFxpZvyDmkSPpGWRvxd","date":"May 5, 2024","link":"https://www.calcalistech.com/ctechnews/article/hyytykbza","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"Acquisition, Healthtech","company":"Alcon Pharmaceuticals","layoffs":"N/A","summary":"Alcon Pharmaceuticals is acquiring Israeli healthtech company Belkin Vision, according to a report filed by BioLight to the Tel Aviv Stock Exchange. Belkin Vision, valued at up to $330 million, has developed a non-contact automated glaucoma laser therapy. The company has raised about $45 million to date, including grants from the European Union and the Israel Innovation Authority. All Belkin shares will be transferred to a wholly-owned subsidiary of Alcon, with BioLight to receive $9 million in cash immediately upon completion of the transaction, and an additional future compensation of up to $10.8 million, depending on meeting milestones.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":9,"key_topics":["Acquisition","Healthtech","Glaucoma Therapy","Belkin Vision","Alcon Pharmaceuticals"],"date_of_event":"N/A","valuation_amount":"$330 million","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Acquisition"],"acquisition_amount":"$330 million","structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"BrMYRcss75DgtGDwr3YAFV43kInHI2fHqa43Y8Y1i3IdeDxVKFPgoY","news_summary":"Alcon acquiring glaucoma laser therapy developer Belkin Vision for up to $330 million | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"extensions":null,"events":null,"hide_reasons":[{"id":"75T5aG1f0dpqYFonup40lXNjO046zUH82TaHW1TAiIMf9aYAsSOl0d","reason":"No relevant activity"},{"id":"7KVi9S7qqUtO0WCsFclwqBEZluejfNYqWC1Uhx0tPHtDxtvxPPaCPH","reason":"No longer active"},{"id":"hoyKAmu4YJEHmhtLwCdeFldSnDwaVbPXOnH0RA9hKHCzAcHO6OOrXd","reason":"Pending approval"},{"id":"TC54H7CXyKO8GmPECkbyKJf8n34r70JlfJTJHfo85exRpLaKI1Efs9","reason":"Pending approval - External entity"}],"timeline":[{"id":"ZjDxgfVQLRvjcD5SqxVhRAnSp0nMG3HgBHa5WeAe52Rkr4n6FSd8R8","hub":null,"date":"2019-04-01","batch":"","token":"","amount":null,"hub_id":null,"source":"","ticker":"ALC","enddate":"","mnatype":null,"eventtype":"POEvent","granttype":null,"valuation":null,"investment":[],"hub_logokey":null,"hub_urlname":null,"wasacquired":null,"delistreason":null,"capitalraised":null,"stockexchange":"SIX","eventvisibility":"Public","amountvisibility":null,"duetoacquisition":null,"isextensionround":null,"token_visibility":"","fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODIkJbHCQw","acquiredcompany_mna":null,"communitycompany_id":null,"isjointventuregrant":null,"acquiredcompany_spac":"Undisclosed","communitycompany_name":null,"communitycompany_type":null,"stockexchange_logokey":"$8SB85SISCfwYkSyUwLjTE2ozNx7CLkx63mQwuJlCCcFmIUyR7m5z8P","acquiredcompany_mna_id":null,"fundingtypefundingtype":null,"acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"communitycompany_hidden":null,"communitycompany_fullurl":null,"communitycompany_logokey":null,"communitycompany_urlname":null,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_logokey":null,"acquiredcompany_mna_urlname":null,"acquiredcompany_mna_homepage":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_homepage":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"acquiredcompany_reverse_homepage":null,"hub_logourl":"/assets/empty-state.svg","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$8SB85SISCfwYkSyUwLjTE2ozNx7CLkx63mQwuJlCCcFmIUyR7m5z8P","communitycompany_logourl":"/assets/empty-state.svg","acquiredcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""},{"id":"xVIT6xUUQTUNlPs0fCCe8Ij1Y7xDRs1oeb9JV2N31uQ1nHW26NdPuA","hub":null,"date":"2019-04-01","batch":"","token":"","amount":null,"hub_id":null,"source":"Alcon Pharmaceuticals","ticker":"ALC","enddate":"","mnatype":null,"eventtype":"POEvent","granttype":null,"valuation":null,"investment":[],"hub_logokey":null,"hub_urlname":null,"wasacquired":null,"delistreason":null,"capitalraised":null,"stockexchange":"NYSE","eventvisibility":"Public","amountvisibility":null,"duetoacquisition":null,"isextensionround":null,"token_visibility":"","fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODIgdygCww","acquiredcompany_mna":null,"communitycompany_id":null,"isjointventuregrant":null,"acquiredcompany_spac":"Undisclosed","communitycompany_name":null,"communitycompany_type":null,"stockexchange_logokey":"$gCUzHIIl5WdaUySSBVfr4ukCJPjuwKJMFXjiY09JCLUNERZRom14T0","acquiredcompany_mna_id":null,"fundingtypefundingtype":null,"acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"communitycompany_hidden":null,"communitycompany_fullurl":null,"communitycompany_logokey":null,"communitycompany_urlname":null,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_logokey":null,"acquiredcompany_mna_urlname":null,"acquiredcompany_mna_homepage":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_homepage":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"acquiredcompany_reverse_homepage":null,"hub_logourl":"/assets/empty-state.svg","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$gCUzHIIl5WdaUySSBVfr4ukCJPjuwKJMFXjiY09JCLUNERZRom14T0","communitycompany_logourl":"/assets/empty-state.svg","acquiredcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""}],"techcommunityinvolvement":null,"tags":["medical-devices"],"investments":[],"funds":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"10,001-50,000","fundingtype":"Multinational","parsedName":"Alcon Pharmaceuticals","logourl":"https://storage.googleapis.com/clean-finder-353810/$3DNKKAH8tfnswTSkxk6Mg1j3ZHKgFaKmE1DpOGckdhercxthLADbvg.jpeg","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$3DNKKAH8tfnswTSkxk6Mg1j3ZHKgFaKmE1DpOGckdhercxthLADbvg.jpeg","teamMembersNumber":1,"nationality":"Foreign","communityinvolvement":[],"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}